The application value of HNF-1β transcription factor in the diagnosis of ovarian clear cell carcinoma

International Journal of Gynecological Pathology

Volumn 35, Issue 1, 2016, Pages 66-71

  Li, Qing ^a   Cheng, Xue ^b,c   Ji, Jie ^b   Zhang, Jingmin ^b   Huang, Wenbin ^d  

^a Shanghai Pudong New Area People's Hospital   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

^c NANJING UNIVERSITY   (China)

^d NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Clear cell carcinoma; HNF 1 transcription factor; Immunohistochemistry; Ovarian cancer

Indexed keywords

HEPATOCYTE NUCLEAR FACTOR 1BETA; TUMOR MARKER;

ARTICLE; CANCER DIAGNOSIS; CLEAR CELL CARCINOMA; COLLOID CARCINOMA; DIAGNOSTIC VALUE; ENDOMETRIOID CARCINOMA; ENDOMETRIUM CARCINOMA; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; OVARY CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENSITIVITY AND SPECIFICITY; TRANSITIONAL CELL CARCINOMA; ADENOCARCINOMA, CLEAR CELL; ADENOCARCINOMA, MUCINOUS; CARCINOMA, ENDOMETRIOID; CARCINOMA, TRANSITIONAL CELL; CYSTADENOCARCINOMA, SEROUS; KRUKENBERG TUMOR; METABOLISM; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; PATHOLOGY;

ADENOCARCINOMA, CLEAR CELL; ADENOCARCINOMA, MUCINOUS; BIOMARKERS, TUMOR; CARCINOMA, ENDOMETRIOID; CARCINOMA, TRANSITIONAL CELL; CYSTADENOCARCINOMA, SEROUS; FEMALE; HEPATOCYTE NUCLEAR FACTOR 1-BETA; HUMANS; IMMUNOHISTOCHEMISTRY; KRUKENBERG TUMOR; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; SENSITIVITY AND SPECIFICITY;

EID: 84952664620     PISSN: 02771691     EISSN: 15387151     Source Type: Journal    
DOI: 10.1097/PGP.0000000000000213     Document Type: Article

References (18)

1. Kurman RJ, Carcangiu ML, Herrington CS, et al. WHO Classification of Tumours of Female Reproductive Organ (M). Lyon: IARC; 2014.
2. Goff BA, Sainz de la Cuesta R, Muntz HG, et al. Clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy in stage III disease. Gynecol Oncol. 1996;60:412-7.
3. Tsuchiya A, Sakamoto M, Yasuda J, et al. Expression profiling in ovarian clear cell carcinoma: identification of hepatocyte nuclear factor-1 as a molecular marker and a possible molecular target for therapy of ovarian clear cell carcinoma. Am J Pathol. 2003;163:2503-12.
4. Kato N, Sasou S, Motoyama T. Expression of hepatocyte nuclear factor-1beta (HNF-1beta) in clear cell tumors and endometriosis of the ovary. Mod Pathol. 2006;19:83-9.
5. Higashiguchi A, Yamada T, Susumu N, et al. Specific expression of hepatocyte nuclear factor-1b in the ovarian clear cell adenocarcinoma and its application to cytological diagnosis. Cancer Sci. 2007;98:387-91.
6. Kato N, Toukairin M, Asanuma I, et al. Immunocytochemistry for hepatocyte nuclear factor-1beta (HNF-1beta): a marker for ovarianclear cell carcinoma. Diagn Cytopathol. 2007;35:193-7.
7. Kao YC, Lin MC, Lin WC, et al. Utility of hepatocyte nuclear factor-1b as a diagnostic marker in ovarian carcinomas with clear cells. Histopathology. 2012;61:760-8.
8. DeLair D, Han G, Irving JA, et al. HNF-1b in ovarian carcinomas with serous and clear cell change. Int J Gynecol Pathol. 2013;32:541-6.
9. Igarashi P, Shao X, McNally BT, et al. Roles of HNF-1b in kidney development and congenital cystic diseases. Kidney Int. 2005;68:1944-7.
10. Bohn S, Thomas H, Turan G, et al. Distinct molecular and morphogenetic properties of mutations in the human HNF1bgene that lead to defective kidney development. J Am Soc Nephrol. 2003;14:2033-41.
11. Coffinier C, Gresh L, Fiette L, et al. Bile system morphogenesis defects and liver dysfunction upon targeted deletion of HNF1b. Development. 2002;129:1829-38.
12. Pontoglio M. Hepatocyte nuclear factor 1, a transcription factor at the crossroads of glucose homeostasis. J Am Soc Nephrol. 2000;11(suppl 16):S140-3.
13. Chuman Y, Bergman A, Ueno T, et al. Napsin A, a member of the aspartic protease family, is abundantly expressed in normal lung and kidney tissue and is expressed in lung adenocarcinomas. FEBS Lett. 1999;462:129-34.
14. Ueno T, Linder S, Elmberger G. Aspartic proteinase napsin is a useful marker for diagnosis of primary lung adenocarcinoma. Br J Cancer. 2003;88:1229-33.
15. Turner BM, Cagle PT, Sainz IM, et al. Napsin A, a new marker for lung adenocarcinoma, is complementary and more sensitive and specific than thyroid transcription factor 1 in the differential diagnosis of primary pulmonary carcinoma: evaluation of 1674 cases by tissue microarray. Arch Pathol Lab Med. 2012;136:163-71.
16. Fadare O, Desouki MM, Gwin K, et al. Frequent expression of napsin A in clear cell carcinoma of the endometrium: potential diagnostic utility. Am J Surg Pathol. 2015;28:111-7.
17. Skirnisdottir I, Bjersand K, Akerud H, et al. Napsin A as a marker of clear cell ovarian carcinoma. BMC Cancer. 2013;13: 524.
18. Fadare O, Zhao C, Khabele D, et al. Comparative analysis of Napsin A, alpha-methylacyl-coenzyme A racemase (AMACR, P504S), and hepatocyte nuclear factor 1 beta as diagnostic markers of ovarian clear cell carcinoma: an immunohistochemical study of 279 ovarian tumours. Pathology. 2015;47: 105-11.